(PharmaNewsWire.Com, March 15, 2017 ) Global Diagnostic Electro Cardiographs Market was worth $ 4042 million in 2016 and estimated to be growing at a CAGR of 6.1%, to reach $5434.67 million by 2021. Diagnostic Electrocardiograph is a device used to record electrical activity of the heart by placing electrodes on a person’s body.
Technological advancements in communication, low power circuit design for safer ECG devices along with portability features, lower power consumption more accuracy and capacity to incorporate latest diagnostic features are the major factors driving the growth of the market. Increasing aging population and growing incidence of lifestyle diseases are also fuelling the growth of Global Diagnostic Electrocardiographs market. However unstable reimbursement regulations, high cost of devices and economic instability are the major factors hindering the growth of the market.
Global market for Diagnostic Electro Cardiographs is segmented by product, Lead type and End User. On the basis of Product the market is further sub segmented into Resting ECG Systems, Stress ECG Systems and Holter Monitors. By Lead Type market is further sub-segmented into Single-Lead Type ECG Devices, 3–6 Lead Type ECG Devices, 12-Lead Type ECG Devices and Other Lead Type Devices. By End user the market is segmented into Hospitals, Rehabilitation Centers, Home /Ambulatory Care research centers, Diagnostic Centers, Clinics, Physician Offices and surgical centers.
The resting ECG devices segment accounted for the largest share owing to increasing aging population and growing incidence of cardiovascular diseases. Holter diagnostic ECG device is estimated to be the fastest growing segment due to technological advancements, which have brought down the prices of these devices.
On the basis of geography global market for diagnostic electrographs is analyzed under various regions namely North America, Europe, Asia-pacific, Latin America and Middle-East and Africa. North America is the largest market for Diagnostic Electrocardiographs Market due to innovations in technology and wide spread awareness about the advantages of electrocardiographs. Asia-Pacific is estimated to be the fastest growing region due to its high patient base and growing healthcare expenditure.
Some of the major companies covered in the report are BPL Ltd, Cardiac Science Corp, Fukuda Denshi Co., Ltd, GE Healthcare, Medtronic, Inc, Philips Healthcare, Spacelabs Healthcare, Inc, Mortara Instrument, Inc, Midmark Corp, Mindray Medical International Ltd, Nihon Kohden Corp, Scottcare Corp, Schiller Ag, Welch Allyn Inc and Cardionet
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
